Jasper Therapeutics, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
Mailing Address 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
Phone 6505491400
Fiscal Year End 1231
EIN 842984849
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 26, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 8-K Current report of material events | December 2, 2025 | View on SEC |
Material Events
8-K Leadership Change January 7, 2026
High Impact
- Jasper Therapeutics announced a significant leadership change, with CEO and President Ron Martell stepping down.
- Jeet Mahal, previously the Chief Operating Officer, has been appointed as the new CEO and President.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
CRISPR Therapeutics AG
CRSP Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.